Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? EntreMed, Inc.
Shares of the biotech company surged nearly 25 percent on over 1 million shares traded Monday after reporting the publication of favorable results of a preclinical study for ENMD-2076 in “triple-negative” breast cancer.
Going forward ... (see research report)
Subscribe to News Feeds